With the increasing prevalence of overweight and obesity, obesity-related metabolic diseases have become a significant threat to public health. Scientific and standardized weight management not only improves metabolic conditions and reduces the risk of chronic diseases but also serves as a key component in achieving the strategic goals of Healthy China. In recent years, glucagon-like peptide-1 receptor agonists (GLP-1RAs) have achieved continuous breakthroughs in weight management and metabolic improvement. However, clinical promotion and standardized use still face challenges such as cognitive disparities and insufficient practice, necessitating academic exchanges to foster consensus and experience sharing.

        To promote the scientific application of GLP-1RA in weight management and enhance the close integration of evidence-based practices with clinical practice, the Chengdu High-Tech Medical Association successfully held the "GLP-1RA Symposium on Weight Management" in Chengdu on October 15, 2025. The conference focused on hot topics such as the latest evidence-based research findings on GLP-1RA, personalized weight management strategies, comprehensive prevention and control of comorbidities, and long-term adherence improvement. Renowned experts from the fields of endocrinology, nutrition, and general medicine were invited to deliver keynote reports and share clinical case studies. The symposium aimed to establish a high-level academic exchange platform for clinicians, researchers, and primary healthcare professionals, jointly advancing the standardization and personalization of weight management, and contributing to the goals of chronic disease prevention and public health improvement.